An Act to amend the Food and Drugs Act (process for approval of new drugs)

This bill is from the 37th Parliament, 3rd session, which ended in May 2004.

Sponsor

Greg Thompson  Progressive Conservative

Introduced as a private member’s bill. (These don’t often become law.)

Status

Outside the Order of Precedence (a private member's bill that hasn't yet won the draw that determines which private member's bills can be debated), as of Feb. 2, 2004
(This bill did not become law.)

Similar bills

C-239 (37th Parliament, 2nd session) An Act to amend the Food and Drugs Act (process for approval of new drugs)
C-338 (37th Parliament, 1st session) An Act to amend the Food and Drugs Act (process for approval of new drugs)

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.

Bill numbers are reused for different bills each new session. Perhaps you were looking for one of these other C-239s:

C-239 (2022) An Act to amend An Act to authorize the making of certain fiscal payments to provinces, and to authorize the entry into tax collection agreements with provinces
C-239 (2020) National Cycling Strategy Act
C-239 (2020) National Cycling Strategy Act
C-239 (2016) Fairness in Charitable Gifts Act
C-239 (2013) An Act to amend the Criminal Code (peace officers)
C-239 (2011) An Act to amend the Criminal Code (peace officers)

Food and Drugs ActRoutine Proceedings

October 23rd, 2002 / 3:45 p.m.


See context

Progressive Conservative

Greg Thompson Progressive Conservative New Brunswick Southwest, NB

moved for leave to introduce Bill C-239, an act to amend the Food and Drugs Act (process for approval of new drugs)

Mr. Speaker, this bill would effectively improve the process of drug approval in Canada. It would speed up the process.

The model that I am looking at in this bill would correspond very closely to the one in the European Community.

There would be an absolute benefit to Canada. The sooner that drugs get on the market and become available to Canadians, the sooner that diseases will be cured and people will not be hospitalized for as long a time. There would be real benefits to Canadians if this bill were passed by the House of Commons.

(Motions deemed adopted, bill read the first time and printed)